Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 Jul;112(3):757–762. doi: 10.1111/j.1476-5381.1994.tb13143.x

A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts.

A F Rump 1, D Acar 1, W Klaus 1
PMCID: PMC1910180  PMID: 7921599

Abstract

1. The functional and anti-ischaemic effects of the phosphodiesterase (PDE)-inhibitors, amrinone, milrinone and levosimendan, a new agent combining PDE-inhibitory with calcium-sensitizing properties, were investigated in rabbit isolated hearts (Langendorff, constant pressure: 70 cmH2O, Tyrode solution, Ca2+ 1.8 mmol l-1, 37 degrees C). Anti-ischaemic effects were studied in electrically-driven hearts (200 beats min-1). Acute regional ischaemia was induced by ligature of a branch of the circumflex coronary artery and quantified from epicardial NADH-fluorescence photography. 2. Cumulative concentration-response curves in spontaneously beating hearts in the presence of isoprenaline (10(-10) M), showed a higher inotropic and coronary vasodilator potency for levosimendan (EC50: 7 x 10(-7) M) compared to milrinone (EC50: 7.7 x 10(-6) M) or amrinone (EC50: 2 x 10(-5) M). Although the maximal coronary dilator activity was similar for the three agents, the maximal inotropic and chronotropic effects were lower for levosimendan than for amrinone or milrinone (P < 0.05). 3. In regionally ischaemic hearts, milrinone (10(-5) M) or levosimendan (5 x 10(-6) M) similarly enhanced the left ventricular pressure (+15-20%) (P < 0.05) and the global coronary flow (+40-50%) (P < 0.05). The epicardial NADH-fluorescence area was significantly diminished by milrinone or levosimendan (-20-30%) (P < 0.05) and there was no significant difference between the anti-ischaemic effects of either agent (P > 0.05). 4. It is concluded that amrinone and milrinone possess similar functional profiles in rabbit isolated hearts and a higher inotropic and chronotropic efficacy than levosimendan.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
757

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baller D., Bretschneider H. J., Hellige G. Validity of myocardial oxygen consumption parameters. Clin Cardiol. 1979 Oct;2(5):317–327. doi: 10.1002/clc.4960020502. [DOI] [PubMed] [Google Scholar]
  2. Barlow C. H., Harken A. H., Chance B. Evaluation of cardiac ischemia by NADH fluroescence photography. Ann Surg. 1977 Dec;186(6):737–740. doi: 10.1097/00000658-197712000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Benotti J. R., Grossman W., Braunwald E., Carabello B. A. Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease. Circulation. 1980 Jul;62(1):28–34. doi: 10.1161/01.cir.62.1.28. [DOI] [PubMed] [Google Scholar]
  4. Flores N. A., Davies R. L., Penny W. J., Sheridan D. J. Coronary microangiography in the guinea pig, rabbit and ferret. Int J Cardiol. 1984 Oct;6(4):459–471. doi: 10.1016/0167-5273(84)90326-7. [DOI] [PubMed] [Google Scholar]
  5. Hafner D., Heinen E., Noack E. Mathematical analysis of concentration-response relationships. Method for the evaluation of the ED50 and the number of binding sites per receptor molecule using the logit transformation. Arzneimittelforschung. 1977;27(10):1871–1873. [PubMed] [Google Scholar]
  6. Harken A. H., Simson M. B., Haselgrove J., Wetstein L., Harden W. R., 3rd, Barlow C. H. Early ischemia after complete coronary ligation in the rabbit, dog, pig, and monkey. Am J Physiol. 1981 Aug;241(2):H202–H210. doi: 10.1152/ajpheart.1981.241.2.H202. [DOI] [PubMed] [Google Scholar]
  7. Herzig J. W., Quast U. On the role of Ca++ binding proteins as possible targets for Ca++ sensitizing agents. Z Kardiol. 1992;81 (Suppl 4):49–55. [PubMed] [Google Scholar]
  8. Holmberg S. R., Williams A. J. Phosphodiesterase inhibitors and the cardiac sarcoplasmic reticulum calcium release channel: differential effects of milrinone and enoximone. Cardiovasc Res. 1991 Jul;25(7):537–545. doi: 10.1093/cvr/25.7.537. [DOI] [PubMed] [Google Scholar]
  9. Jentzer J. H., Lejemtel T. H., Sonnenblick E. H., Kirk E. S. Beneficial effect of amrinone on myocardial oxygen consumption during acute left ventricular failure in dogs. Am J Cardiol. 1981 Jul;48(1):75–83. doi: 10.1016/0002-9149(81)90574-9. [DOI] [PubMed] [Google Scholar]
  10. Maxwell M. P., Hearse D. J., Yellon D. M. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res. 1987 Oct;21(10):737–746. doi: 10.1093/cvr/21.10.737. [DOI] [PubMed] [Google Scholar]
  11. Michailova A. P., Spassov V. Z. Theoretical model and computer simulation of excitation-contraction coupling of mammalian cardiac muscle. J Mol Cell Cardiol. 1992 Jan;24(1):97–104. doi: 10.1016/0022-2828(92)91163-y. [DOI] [PubMed] [Google Scholar]
  12. Nienaber C., Gottwik M., Winkler B., Schaper W. The relationship between the perfusion deficit, infarct size and time after experimental coronary artery occlusion. Basic Res Cardiol. 1983 Mar-Apr;78(2):210–226. doi: 10.1007/BF01906674. [DOI] [PubMed] [Google Scholar]
  13. Rump A. F., Blazincic B., Klaus W. Effect of amrinone and milrinone on myocardial ischemia extent and infarct size in isolated rabbit hearts. Arzneimittelforschung. 1993 Dec;43(12):1262–1266. [PubMed] [Google Scholar]
  14. Rump A. F., Rösen R., Klaus W. Cardioprotection by superoxide dismutase: a catecholamine-dependent process? Anesth Analg. 1993 Feb;76(2):239–246. doi: 10.1213/00000539-199302000-00007. [DOI] [PubMed] [Google Scholar]
  15. Rump A. F., Rösen R., Klaus W. Free radical scavenging properties of beta-adrenoceptor blockers are not relevant for cardioprotection in isolated rabbit hearts. Naunyn Schmiedebergs Arch Pharmacol. 1993 Oct;348(4):431–434. doi: 10.1007/BF00171344. [DOI] [PubMed] [Google Scholar]
  16. Rump A. F., Rösen R., Sigmund B., Fuchs J., Dhein S., Klaus W. Beneficial effect of amrinone on the size of acute regional ischemia in isolated rabbit hearts. J Cardiothorac Vasc Anesth. 1993 Oct;7(5):573–578. doi: 10.1016/1053-0770(93)90317-e. [DOI] [PubMed] [Google Scholar]
  17. Ventura C., Miller R., Wolf H. P., Beier N., Jonas R., Klockow M., Lues I., Hano O., Spurgeon H. A., Lakatta E. G. Novel diazinone derivatives separate myofilament Ca2+ sensitization and phosphodiesterase III inhibitory effects in guinea pig myocardium. Circ Res. 1992 Jun;70(6):1081–1090. doi: 10.1161/01.res.70.6.1081. [DOI] [PubMed] [Google Scholar]
  18. von der Leyen H., Schmitz W., Scholz H., Scholz J. New positive inotropic agents acting by phosphodiesterase inhibition or alpha 1-adrenergic stimulation. Pharmacol Res. 1989 Jul-Aug;21(4):329–337. doi: 10.1016/1043-6618(89)90150-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES